Patients' preferences and perceptions of point-of-care technologies: Survey results from the lung disease community.

Authors

Bernard Ofosuhene, Heaven Tatere, Miraf Yeshaneh Tatere, Taylor Orwig, Ziyue Wang, Apurv Soni, Craig M Lilly, Stephen Anders, Denise Dunlap, Honghuang Lin, Allan Walkey, Chiara Ghezzi, Mary Ann Picard, Varun Ayyaswami, Bryan Buchholz, David D McManus, Nathaniel Hafer

Published in

Journal of clinical and translational science. Volume 10. Issue 1. Pages e128. Epub Jul 13, 2026.

Abstract

Point-of-care technology (POCT) has expanded rapidly, particularly since the COVID-19 pandemic. However, less is known about which POCT applications and features patients and caregivers prioritize for lung disease management.
We refined a patient-facing survey based on feedback from an online focus group recruited through community and advocacy volunteer networks. The survey was then administered via ResearchMatch to uncompensated U.S. volunteers, who indicated interest in lung disease research (April 1 to May 14, 2025; 6,333 invitations). POCT perceptions were measured via a 10-point Likert scale.
We received 214 responses (3.4% response rate). Respondents were predominantly patients (79%), female (71%), and older than 60 years (59%). Mean ratings suggested strong perceived benefits across nine POCT benefits and low concern across most drawbacks. The greatest concern was insurance coverage for POCT-associated costs (mean score: 6.7/10). Obstructive lung conditions were most frequently prioritized for future POCT applications.
Among a national sample of ResearchMatch volunteers affected by lung disease, interest in POCT was high, and insurance coverage remained the most salient concern. By describing preferences and concerns of patients, this study informs future design, regulatory approval, and clinical integration. These findings provide evidence for POCT developers, clinicians, and policymakers focused on improving patient-centered care.

PMID:
42534423
Bibliographic data and abstract were imported from PubMed on 31 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.